Speedel CEO Alice Huxley: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
Exec discusses Novartis’ hypertension treatment, Tekturna, which Speedel developed, as well as the benefits of other renin inhibitors in the Swiss biotech’s pipeline.
Exec discusses Novartis’ hypertension treatment, Tekturna, which Speedel developed, as well as the benefits of other renin inhibitors in the Swiss biotech’s pipeline.